ALDH18A1 and neoplasm: Features of the RP1 virus that represent improvements over T-VEC include the engineered overexpression of US11 designed to enhance replication within tumors having a defective antiviral response, and transgenic expression of GALV-GP-R- designed to enhance direct tumor killing via syncytia formation.